292 related articles for article (PubMed ID: 28295306)
1. Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.
Arosarena OA; Barr EW; Thorpe R; Yankey H; Tarr JT; Safadi FF
J Cell Physiol; 2018 Jan; 233(1):409-421. PubMed ID: 28295306
[TBL] [Abstract][Full Text] [Related]
2. Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.
Arosarena OA; Dela Cadena RA; Denny MF; Bryant E; Barr EW; Thorpe R; Safadi FF
J Cell Physiol; 2016 Aug; 231(8):1761-70. PubMed ID: 26636434
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
[TBL] [Abstract][Full Text] [Related]
4. Oleic acid-induced ANGPTL4 enhances head and neck squamous cell carcinoma anoikis resistance and metastasis via up-regulation of fibronectin.
Shen CJ; Chan SH; Lee CT; Huang WC; Tsai JP; Chen BK
Cancer Lett; 2017 Feb; 386():110-122. PubMed ID: 27865799
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.
O-charoenrat P; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Clin Exp Metastasis; 1999; 17(7):631-9. PubMed ID: 10845563
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion.
O-Charoenrat P; Rhys-Evans P; Modjtahedi H; Court W; Box G; Eccles S
Int J Cancer; 2000 May; 86(3):307-17. PubMed ID: 10760816
[TBL] [Abstract][Full Text] [Related]
8. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
[TBL] [Abstract][Full Text] [Related]
9. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas.
Görögh T; Beier UH; Bäumken J; Meyer JE; Hoffmann M; Gottschlich S; Maune S
Head Neck; 2006 Jan; 28(1):31-9. PubMed ID: 16265652
[TBL] [Abstract][Full Text] [Related]
10. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
11. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
[TBL] [Abstract][Full Text] [Related]
12. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.
Wu Y; Palad AJ; Wasilenko WJ; Blackmore PF; Pincus WA; Schechter GL; Spoonster JR; Kohn EC; Somers KD
Clin Cancer Res; 1997 Nov; 3(11):1915-21. PubMed ID: 9815580
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-2 and -14 in p16-positive and -negative HNSCC after exposure To 5-FU and docetaxel In Vitro.
Aderhold C; Umbreit C; Faber A; Birk R; Sommer JU; Hörmann K; Schultz JD
Anticancer Res; 2014 Sep; 34(9):4929-37. PubMed ID: 25202075
[TBL] [Abstract][Full Text] [Related]
15. Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression.
Canel M; Secades P; Garzón-Arango M; Allonca E; Suarez C; Serrels A; Frame M; Brunton V; Chiara MD
Br J Cancer; 2008 Apr; 98(7):1274-84. PubMed ID: 18349846
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis
Hsu JY; Chang JY; Chang KY; Chang WC; Chen BK
FASEB J; 2017 Oct; 31(10):4265-4276. PubMed ID: 28596235
[TBL] [Abstract][Full Text] [Related]
17. Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in vitro cell lines co-cultured with fibroblasts.
Tokumaru Y; Fujii M; Otani Y; Kameyama K; Imanishi Y; Igarashi N; Kanzaki J
Cancer Lett; 2000 Mar; 150(1):15-21. PubMed ID: 10755382
[TBL] [Abstract][Full Text] [Related]
18. MMP-10/stromelysin-2 promotes invasion of head and neck cancer.
Deraz EM; Kudo Y; Yoshida M; Obayashi M; Tsunematsu T; Tani H; Siriwardena SB; Keikhaee MR; Qi G; Iizuka S; Ogawa I; Campisi G; Lo Muzio L; Abiko Y; Kikuchi A; Takata T
PLoS One; 2011; 6(10):e25438. PubMed ID: 21998657
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo.
Zhang W; Matrisian LM; Holmbeck K; Vick CC; Rosenthal EL
BMC Cancer; 2006 Mar; 6():52. PubMed ID: 16515711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
